Showing results (211-220 of 224) with videos related to

Sort By:
Pageof 23
Allergy|August 29, 1998
Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensB R Balda, H Wolf, C Baumgarten, et al.
The Journal of Biological Chemistry|August 20, 2009
Chemical interrogation of FOXO3a nuclear translocation identifies potent and selective inhibitors of phosphoinositide 3-kinasesWolfgang Link, Julen Oyarzabal, Beatriz G Serelde, et al.
Journal of Medicinal Chemistry|April 15, 2005
3-Aminopyrazole inhibitors of CDK2/cyclin A as antitumor agents. 2. Lead optimizationPaolo Pevarello, Maria Gabriella Brasca, Paolo Orsini, et al.
Cancer Letters|November 6, 2010
Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibitionCarmen Blanco-Aparicio, Ana María García Collazo, Julen Oyarzabal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2021
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF InhibitorJürgen Wichmann, Caroline Rynn, Thomas Friess, et al.
European Journal of Medicinal Chemistry|February 26, 2019
Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitorsSonia Martínez-González, Sonsoles Rodríguez-Arístegui, Cristina Ana Gómez de la Oliva, et al.
Bioorganic & Medicinal Chemistry Letters|July 24, 2012
Rapid identification of ETP-46992, orally bioavailable PI3K inhibitor, selective versus mTORSonia Martínez González, Ana Isabel Hernández, Carmen Varela, et al.
Frontiers in Immunology|November 6, 2024
Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitorsFelix Scheuplein, Florian Renner, John E Campbell, et al.
Journal of Medicinal Chemistry|September 30, 2022
Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with OsimertinibUlrike Obst-Sander, Antonio Ricci, Bernd Kuhn, et al.
Haematologica|July 18, 2012
Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomasEsperanza Martín-Sánchez, Socorro M Rodríguez-Pinilla, Margarita Sánchez-Beato, et al.
Pageof 23